Events and
Presentations

September 27, 2018 4:30 PM EDT : Key Opinion Leader Symposium on Portal Hypertension
Open Webcast
September 27

View All

Our
Programs

Emricasan is a first-in-class, orally active caspase inhibitor designed to reduce the activity of ...

Learn More